Can you take a break from tirzepatide or semaglutide?
A break is possible, but weight usually returns. In trials, people switched from tirzepatide (Mounjaro, Zepbound) to placebo saw their weight rise 14% over a year, and those switched from semaglutide (Ozempic, Wegovy) 6.9% over 48 weeks. The US Wegovy label says to restart at a lower dose after missing 2 or more weekly doses in a row.
What happens to your weight during a break?
In two trials where people swapped the medicine for a dummy injection (placebo), much of the weight they had lost came back within a year.56
In SURMOUNT-4, 670 people lost an average of 20.9% of their weight over 36 weeks of tirzepatide. Over the next 52 weeks, weight rose 14.0% on placebo. It fell a further 5.5% in those who stayed on tirzepatide.15 The placebo group weighed 85.8 kg on average at the switch, so a 14% rise is about 12 kg.1
In STEP 4, people lost 10.6% over 20 weeks of semaglutide. Over the next 48 weeks, weight rose 6.9% on placebo and fell 7.9% on semaglutide.6 In the STEP 1 extension, people regained two-thirds of the weight they had lost within a year of stopping semaglutide.7 These trials stopped the medicine for about a year, so they don't show what a break of a few weeks does.
What do the labels say about missed doses?
A late tirzepatide dose can be taken within 4 days, and a late semaglutide injection within 5 days. After that, skip it.13
The US Zepbound label gives the 4-day (96-hour) window. Your weekly day can move, as long as doses stay at least 3 days (72 hours) apart.1 The US Wegovy label says to take a missed injection if the next one is more than 2 days away. If 2 or more doses in a row are missed, it says to restart the dose rise at a lower dose, to lower the risk of stomach and bowel side effects.2
The EU Wegovy label says a lower restart dose "should be considered" when more doses are missed.3 The US Zepbound and EU Mounjaro labels we read give no rule for restarting after several missed doses.14
Does a break make the medicine work better afterwards?
We found no human trial showing that a break restores or boosts the effect, and a 2026 study in mice pointed the other way.8
In that study, obese mice had 2 rounds of 2 weeks on semaglutide and 2 weeks off. They regained weight quickly after each stop and did not reach their earlier low point on restart. They ended up 20% heavier than mice treated without breaks. The authors say this still needs testing in people.8
Both medicines leave the body slowly. Semaglutide stays in the blood for about 5 to 7 weeks after the last dose.2 Tirzepatide's half-life, the time for half of it to leave the body, is about 5 to 6 days.1 The NHS says not to stop suddenly, and that with type 2 diabetes stopping could affect your blood sugar.910 The NHS semaglutide page says your doctor may suggest reducing your dose gradually.10 Our guide to stopping (US edition) covers what follows.
Do you need a break before surgery?
The US labels say there is not enough data to know whether pausing before surgery lowers the risk of food staying in the stomach.12
Both medicines slow how fast the stomach empties. There have been rare reports of people breathing stomach contents into the lungs (pulmonary aspiration). This happened under general anaesthesia or deep sedation, even after fasting as told. The US Zepbound and Wegovy labels ask you to tell your healthcare team before any planned surgery or procedure.12
What do people on GLP-1 medicines report about taking a break?
From public patient forums: 30 Reddit threads in r/Zepbound, r/Mounjaro, r/mounjarouk, r/WegovyWeightLoss, r/Semaglutide and r/MounjaroMaintenance, with posts from October 2025 to October 2026. Personal reports, not medical evidence.
What people describe
- Matches the trials Many describe regaining weight after stopping. In SURMOUNT-4 and STEP 4, weight rose over about a year on placebo but kept falling on the medicine; these trials did not test short breaks.56
- Not studied Many others say they gained little or nothing over a short break, mostly while tracking food closely. We found no trial of breaks this short.
- Not studied Accounts of restarting are mixed. Many say the medicine felt weaker at first, while many others say it worked well again. We found no human study of either.
- Matches the label Several say stomach and bowel side effects came back or felt worse on restart. The US Wegovy label says a lower restart dose after 2 or more missed doses lowers this risk.2
Advice people share
- Matches the trials Many advise against planned breaks and treat the medicine as long term. The STEP 1 extension authors concluded that ongoing treatment seems to be needed to keep the improvements.7
- Matches the label Several suggest asking about a lower dose, rather than stopping, when a dose feels too strong. The US Zepbound label allows a lower maintenance dose if one is not tolerated.1
- Matches the label Several say not to go straight back to an old top dose after a gap of weeks. The US Wegovy label says to restart the dose rise at a lower dose after 2 or more missed doses.2
- Label says otherwise Several posts describe planned stop-and-restart cycles to "reset" the medicine, or stretching the gap between doses. The labels set a once-weekly schedule, with a missed-dose window of 4 days for tirzepatide and 5 days for semaglutide injection.13
In your country
Every label we read gives the same missed-dose windows, but semaglutide labels word the restart after several missed doses differently. We could not open labels for India, Saudi Arabia or the UAE.
Australia
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.
Label: The Australian Wegovy label says that if more doses are missed, a lower restart dose "should be considered", rather than the US label's firmer instruction.13
Emergency number: 000
What happens when you stop a GLP-1 like Wegovy or Mounjaro? (Australia guide)
Canada
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.
Label: The Canadian Wegovy monograph says that after more than 2 missed doses in a row, dosing can resume as scheduled or, if needed, restart with the dose rise.12
Emergency number: 911
What happens when you stop a GLP-1 like Wegovy, Ozempic or Zepbound? (Canada guide)
France
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).
Label: The EU Wegovy label says that if more doses are missed, a lower restart dose "should be considered", rather than the US label's firmer instruction.3
Emergency number: 15 or 112
Germany
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.
Label: The EU Wegovy label says that if more doses are missed, a lower restart dose "should be considered", rather than the US label's firmer instruction.3
Emergency number: 112
India
Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).
Label: We could not find an Indian label to open, so this page relies on the US labels and EU product information cited above.
Emergency number: 112
What happens when you stop a GLP-1 like Ozempic or Mounjaro? (India guide)
Saudi Arabia
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.
Label: We could not find a Saudi label to open, so this page relies on the US labels and EU product information cited above.
Emergency number: 997 or 911
United Arab Emirates
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.
Label: We could not find a UAE label to open, so this page relies on the US labels and EU product information cited above.
Emergency number: 998 for an ambulance, or 999
What happens when you stop a GLP-1 like Ozempic or Mounjaro? (UAE guide)
United Kingdom
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.
Label: The UK Wegovy label says that if more doses are missed, a lower restart dose "should be considered", rather than the US label's firmer instruction.11
Emergency number: 999
What happens when you stop a GLP-1 like Wegovy or Mounjaro? (UK guide)
United States
Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).
Label: The answer above applies.
Emergency number: 911
What happens when you stop a GLP-1 like Wegovy or Zepbound? (US guide)
Contact your prescriber or a doctor right away if you have severe or persistent stomach or bowel symptoms, or if you have missed Wegovy for 2 or more weeks in a row and need to restart.12 Do the same if you have type 2 diabetes and are stopping, because it could affect your blood sugar.910
Read the full picture
Related questions
Sources
- US Zepbound (tirzepatide) prescribing information, Eli Lilly. pi.lilly.com
- US Wegovy (semaglutide) prescribing information, Novo Nordisk. novo-pi.com
- EU Wegovy (semaglutide) Summary of Product Characteristics, European Medicines Agency. ema.europa.eu
- EU Mounjaro (tirzepatide) Summary of Product Characteristics, European Medicines Agency. ema.europa.eu
- Aronne LJ, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA. 2024. doi.org/10.1001/jama.2023.24945
- Rubino D, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA. 2021. doi.org/10.1001/jama.2021.3224
- Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022. doi.org/10.1111/dom.14725
- Son AJ, et al. Cycling GLP-1 receptor agonist treatment induces therapeutic resistance and increased adiposity. JCI Insight. 2026 (research letter, mouse study). insight.jci.org
- NHS. Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. nhs.uk
- NHS. Semaglutide: a medicine to manage type 2 diabetes or treat obesity. nhs.uk
- UK Wegovy FlexTouch (semaglutide) Summary of Product Characteristics, emc. medicines.org.uk
- Canadian Wegovy (semaglutide) Product Monograph, Health Canada. pdf.hres.ca
- Australian Wegovy (semaglutide) Product Information. medsinfo.com.au
- American College of Emergency Physicians. Know When to Go. emergencyphysicians.org
Last checked Nov 16, 2026 · Next review due Nov 16, 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on Nov 16, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write